<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-142367</identifier>
<setSpec>1139-8264</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Role of Breast MRI to detect breast ductal carcinoma in situ</dc:title>
<dc:description xml:lang="en">Objective. To determine the ability of preoperative breast MRI to stevaluate in situ component associated to invasive carcinoma and pure CDIS. Material and methods: we included patients diagnosed with invasive breast carcinoma or ductal carcinoma in situ in the Hospital of Our Lady of Grace Zaragoza between January 2010 and December 2013. They all had studies with mammography and / or ultrasound and were operated on the center of diagnosis with the final pathological study as 'gold standard'. Results: MRI determined correctly all cases of CDIS associated to invasive carcinoma and the 93.54 % of pure DCIS Conclusions: MRI is the best imaging test to evaluate CDIS (AU)</dc:description>
<dc:creator>Cantos García, C</dc:creator>
<dc:creator>Arnal Burró, A</dc:creator>
<dc:creator>Asensio Díaz, E</dc:creator>
<dc:creator>Rodriguez Bújez, A</dc:creator>
<dc:creator>Pascual Arévalo, Y</dc:creator>
<dc:creator>Plaza Loma, S</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Objetivo: conocer la capacidad de la RNM mamaria preoperatoria para valorar componente in situ asociado al carcinoma infiltrante y el CDIS puro. Material y métodos: incluímos a las pacientes con diagnóstico de carcinoma de mama infiltrante o carcinoma ductal in situ en el Hospital nuestra Señora de Gracia de Zaragoza entre enero 2010 y diciembre 2013. Todas ellas tenían estudios con mamografía y/o ecografía y fueron operadas en el mismo centro del diagnóstico con el estudio anatomopatológico final como 'prueba de oro'. Resultados: la RNM determina correctamente todos los casos de carcinoma ductal in situ asociado al carcinoma infiltrante y el 93,54% de los CDIS puros Conclusiones: la RNM es la técnica de imagen que mejor determina el CDIS (AU)</dc:description>
<dc:source>Rev. esp. investig. quir;18(3): 113-116, 2015. graf</dc:source>
<dc:identifier>ibc-142367</dc:identifier>
<dc:title xml:lang="es">Papel de la RNM mamaria para la detencción del carcinoma ductal in situ</dc:title>
<dc:subject>^d31805^s29166</dc:subject>
<dc:subject>^d22935^s22045</dc:subject>
<dc:subject>^d31593^s29166</dc:subject>
<dc:subject>^d22935^s22074</dc:subject>
<dc:subject>^d23405^s22045</dc:subject>
<dc:subject>^d28607</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d22935^s22039</dc:subject>
<dc:subject>^d2330^s29166</dc:subject>
<dc:subject>^d29310</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d28630</dc:subject>
<dc:type>article</dc:type>
<dc:date>201500</dc:date>
</metadata>
</record>
</ibecs-document>
